MUC5B: a good target for future therapy in pulmonary fibrosis?
- PMID: 23329274
- DOI: 10.1136/thoraxjnl-2012-202957
MUC5B: a good target for future therapy in pulmonary fibrosis?
Comment on
-
Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosis.Thorax. 2013 May;68(5):436-41. doi: 10.1136/thoraxjnl-2012-201786. Epub 2013 Jan 15. Thorax. 2013. PMID: 23321605
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical